This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

AmeriBen / IEC Group Chooses Elsevier's MEDai

Stocks in this article: ENL RUK

ORLANDO, Florida, October 15, 2012 /PRNewswire/ --

Risk Navigator Clinical ® to provide AmeriBen with population management  and analytics solution

Elsevier's MEDai, which empowers payers and providers to transform care delivery and streamline operations through actionable analytics, today announced a new licensing agreement with AmeriBen/IEC Group, a full-service TPA (third-party administrator) and the largest group in the Northwest possessing both human resource consulting and benefit administration services, for MEDai's Risk Navigator Clinical® software.  MEDai's Risk Navigator Clinical will assist AmeriBen, which manages more than 150,000 lives, in its population management.  

MEDai will provide AmeriBen with Risk Navigator Clinical, a robust solution to analyze and understand their care populations, and execute on strategies to improve the quality of care, reduce costs and waste, and ultimately impact health for their members.

"Risk Navigator Clinical will help AmeriBen as a TPA to promote clinical integration and care coordination in the various employee groups we serve," said Ben Wright, Chief Financial Officer and VP of Strategic Initiatives, AmeriBen.  "We are very excited to turn membership data into actionable information from which we will be able to provide improved quality, better outcomes in delivered care and reduced costs through analytical modeling to our clients."

Risk Navigator Clinical leverages predictive analytics to transform raw data into intelligent insight that payers can use to allocate resources efficiently and intervene before adverse, costly outcomes occur. Through an easy-to-use web interface, Risk Navigator's results outline areas that provide the greatest potential for intervention and management, allowing stakeholders to improve operations and set competitive premium rates.

"We are pleased to integrate Risk Navigator Clinical into AmeriBen to help it manage its clients' populations, cut costs and improve overall health though analytic modeling," said Thomas Zajac, President of Elsevier's MEDai.  "Both AmeriBen/IEC Group and MEDai believe that this relationship translates into a powerful new value proposition for the many members overseen by AmeriBen."

For more information, please visit or call +1-800-446-3324.

About AmeriBen

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs